BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7121431)

  • 1. [The probable anorexigenic effect of naloxone in the Prader-Labhart-Willi syndrome].
    Mascherpa G; Cogliati F; Mauri R; Resentini M
    Minerva Pediatr; 1982 Aug 15-31; 34(15-16):675. PubMed ID: 7121431
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of naloxone on hyperphagia in Prader-Willi syndrome.
    Kyriakides M; Silverstone T; Jeffcoate W; Laurance B
    Lancet; 1980 Apr; 1(8173):876-7. PubMed ID: 6103230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Self-induced cutaneous lesions in Prader-Willi syndrome].
    Plantin P; Milochau P; Broussine L; Blondin G
    Ann Dermatol Venereol; 1997; 124(5):390-2. PubMed ID: 9739896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone.
    Zipf WB; Berntson GG
    Am J Clin Nutr; 1987 Aug; 46(2):277-81. PubMed ID: 3618531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prader-Labhart-Willi syndrome].
    Zajac J; BoznaƄski A
    Pediatr Pol; 1985; 60(11-12):798-801. PubMed ID: 3835533
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychopharmacogenetic aspects of Prader-Willi syndrome.
    Tu JB; Hartridge C; Izawa J
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1137-40. PubMed ID: 1429418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial.
    Selikowitz M; Sunman J; Pendergast A; Wright S
    Arch Dis Child; 1990 Jan; 65(1):112-4. PubMed ID: 2405783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone and Prader-Willi syndrome.
    McCloy RF; McCloy J
    Lancet; 1980 Jun; 1(8183):1418. PubMed ID: 6104204
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prader-Labhart-Willi syndrome with precocious puberty. (author's transl)].
    Walterspiel JN; Wolff J; Heinze E
    Klin Padiatr; 1981 Mar; 193(2):120-1. PubMed ID: 7194936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prader-Labhart-Willi syndrome in infants].
    Schmeling H; Gillessen-Kaesbach G; Schulte-Mattler U; Burdach S; Horneff G
    Klin Padiatr; 2002; 214(2):51-3. PubMed ID: 11972309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
    Schmidt H; Bechtold S; Schwarz HP
    Eur J Med Res; 2000 Jul; 5(7):307-10. PubMed ID: 10903191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mazindol in two patients with Prader-Willi syndrome.
    Itoh M; Koeda T; Ohno K; Takeshita K
    Pediatr Neurol; 1995 Nov; 13(4):349-51. PubMed ID: 8771175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral findings in a child with Prader-Labhart-Willi syndrome.
    Salako NO; Ghafouri HM
    Quintessence Int; 1995 May; 26(5):339-41. PubMed ID: 7568756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sexual development in the Prader-Labhart-Willi syndrome].
    Garty B; Kauli R
    Harefuah; 1982 Jul; 103(1-2):28-9. PubMed ID: 7160750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prader-Willi Labhart syndrome].
    Tangsrud SE
    Tidsskr Nor Laegeforen; 1978 Jun; 98(16):839-40. PubMed ID: 675628
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of extreme obesity in a case of Prader-Willi-Labhart-syndrome (author's transl)].
    Widhalm K; Deutsch J
    Padiatr Padol; 1976; 11(1):297-304. PubMed ID: 1250628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome.
    Eiholzer U; Grieser J; Schlumpf M; l'Allemand D
    Horm Res; 2007; 68(4):178-84. PubMed ID: 17374959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
    Bakker B; Maneatis T; Lippe B
    Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of Prader-Willi syndrome with long-term mazindol treatment.
    Inui A; Uemoto M; Takamiya S; Shibuya Y; Baba S; Kasuga M
    Arch Intern Med; 1997 Feb; 157(4):464. PubMed ID: 9046903
    [No Abstract]   [Full Text] [Related]  

  • 20. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
    Tauber M; Cutfield W
    Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.